[HTML][HTML] The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape
D Zipinotti dos Santos, JC de Souza… - Cell Communication and …, 2023 - Springer
Background Breast cancer (BC) is the second most frequent type of cancer in the world and
most common among women, configuring a major challenge to global health. BC is a …
most common among women, configuring a major challenge to global health. BC is a …
[HTML][HTML] Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
C Xue, Q Yao, X Gu, Q Shi, X Yuan, Q Chu… - Signal transduction and …, 2023 - nature.com
The Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway
is an evolutionarily conserved mechanism of transmembrane signal transduction that …
is an evolutionarily conserved mechanism of transmembrane signal transduction that …
Combining TIGIT blockade with MDSC inhibition hinders breast cancer bone metastasis by activating antitumor immunity
L Monteran, N Ershaid, Y Scharff, Y Zoabi… - Cancer …, 2024 - aacrjournals.org
Bone is the most common site of breast cancer metastasis. Bone metastasis is incurable and
is associated with severe morbidity. Utilizing an immunocompetent mouse model of …
is associated with severe morbidity. Utilizing an immunocompetent mouse model of …
[HTML][HTML] Unraveling the role of hepatic PGC1α in breast cancer invasion: a new target for therapeutic intervention?
Breast cancer (BC) is the most common cancer among women worldwide and the main
cause of cancer deaths in women. Metabolic components are key risk factors for the …
cause of cancer deaths in women. Metabolic components are key risk factors for the …
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
H Mo, Y Yu, X Sun, H Ge, L Yu, X Guan, J Zhai, A Zhu… - Nature Medicine, 2024 - nature.com
It remains unclear whether metronomic chemotherapy is superior to conventional
chemotherapy when combined with immune checkpoint blockade. Here we performed a …
chemotherapy when combined with immune checkpoint blockade. Here we performed a …
[HTML][HTML] High numbers of CD163+ tumor-associated macrophages predict poor prognosis in HER2+ breast cancer
MM Jääskeläinen, R Tumelius, K Hämäläinen, K Rilla… - Cancers, 2024 - mdpi.com
Simple Summary While tumor-associated macrophages (TAMs) are known to be associated
with a poor prognosis in breast cancer (BC) in general, how they influence different BC …
with a poor prognosis in breast cancer (BC) in general, how they influence different BC …
[HTML][HTML] Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks
H Guo, C Zhou, M Zheng, J Zhang, H Wu, Q He… - Pharmacological …, 2024 - Elsevier
The endocytic trafficking pathway is a highly organized cellular program responsible for the
regulation of membrane components and uptake of extracellular substances. Molecules …
regulation of membrane components and uptake of extracellular substances. Molecules …
Type‐I protein arginine methyltransferase inhibition primes anti‐programmed cell death protein 1 immunotherapy in triple‐negative breast cancer
S Zhang, L Guo, Z Zhang, X Liu, W Chen, Y Wei… - Cancer, 2024 - Wiley Online Library
Background Immune‐checkpoint blockade (ICB) therapy shows promise for treating
aggressive triple‐negative breast cancer (TNBC). However, only some patients benefit from …
aggressive triple‐negative breast cancer (TNBC). However, only some patients benefit from …
Betulinic acid in the treatment of breast cancer: Application and mechanism progress
H Mu, Y Sun, B Yuan, Y Wang - Fitoterapia, 2023 - Elsevier
Betulinic acid (BA) is a pentacyclic triterpene compound, which can be obtained by
separation, chemical synthesis and biotransformation. BA has excellent biological activities …
separation, chemical synthesis and biotransformation. BA has excellent biological activities …
[HTML][HTML] Tailoring therapies to counter the divergent immune landscapes of breast cancer
Breast cancer remains a significant clinical concern affecting millions of women worldwide.
Immunotherapy is a rapidly growing drug class that has revolutionized cancer treatment but …
Immunotherapy is a rapidly growing drug class that has revolutionized cancer treatment but …